# Karuna Therapeutics > biopharmaceutical company **Wikidata**: [Q113503524](https://www.wikidata.org/wiki/Q113503524) **Source**: https://4ort.xyz/entity/karuna-therapeutics ## Summary Karuna Therapeutics is a biopharmaceutical company headquartered in Boston, Massachusetts. Founded in 2009, it operates within the pharmaceutical industry. As a public company, Karuna Therapeutics offers its securities for sale to the general public and is traded on the Nasdaq stock exchange under the ticker symbol KRTX. ## Key Facts * **Inception:** Karuna Therapeutics was founded in 2009. * **Industry:** It operates within the pharmaceutical industry. * **Headquarters:** The company's headquarters are located in Boston. * **Public Listing:** Karuna Therapeutics is a public company, with its shares traded on the Nasdaq stock exchange under the ticker symbol KRTX since June 28, 2019. * **Central Index Key (CIK):** Its CIK is 0001771917. * **Online Presence:** The company maintains an official website at https://karunatx.com/ and a Twitter account @karunapharma, active since September 10, 2018, as of March 6, 2023. It also has a LinkedIn presence under the ID 'karuna-therapeutics'. * **Aliases:** The company is also known as Karuna Therapeutics, Inc. * **Wikipedia Presence:** Information about Karuna Therapeutics is available in Japanese on Wikipedia. ## FAQs **What type of company is Karuna Therapeutics?** Karuna Therapeutics is a biopharmaceutical company that focuses on developing new treatments within the pharmaceutical industry. It is also classified as a public company, meaning its shares are available for purchase by the general public. **When and where was Karuna Therapeutics established?** Karuna Therapeutics was founded in 2009 and has its headquarters situated in Boston, Massachusetts. **Is Karuna Therapeutics a publicly traded company?** Yes, Karuna Therapeutics is a public company. Its shares are traded on the Nasdaq stock exchange under the ticker symbol KRTX, a status it has held since June 28, 2019. **How can I find more information about Karuna Therapeutics online?** You can visit Karuna Therapeutics' official website at https://karunatx.com/. The company also maintains a presence on Twitter under the handle @karunapharma and on LinkedIn with the ID 'karuna-therapeutics'. ## Why It Matters Karuna Therapeutics plays a significant role within the pharmaceutical industry as a biopharmaceutical company, contributing to the development of potential new therapies. Its status as a public company is crucial, as it allows the firm to raise substantial capital from a broad base of investors by offering its securities for sale to the general public. This mechanism is vital for funding the extensive research, development, and clinical trials inherent in the capital-intensive biopharmaceutical sector, thereby enabling innovation and the potential introduction of new medical solutions. Being publicly traded also subjects the company to regulatory oversight and disclosure requirements, which promotes transparency for its shareholders and the broader market. ## Notable For * Operating as a biopharmaceutical company focused on developing new treatments. * Being a public company whose shares are traded on the Nasdaq stock exchange under the ticker KRTX since June 28, 2019. * Having its headquarters in Boston, a prominent hub for the biopharmaceutical industry. ## Body ### Overview Karuna Therapeutics is a biopharmaceutical company, also known by its full legal name, Karuna Therapeutics, Inc. It operates within the broader pharmaceutical industry, focusing on the development of new treatments. The company's operations are supported by its status as a public entity, allowing it to engage with a wide range of investors. ### Founding and Location The company was established in 2009, marking its inception in the biopharmaceutical landscape. Karuna Therapeutics has strategically located its headquarters in Boston, Massachusetts, a city recognized globally as a significant center for biotechnology and pharmaceutical innovation. ### Industry Focus Karuna Therapeutics is dedicated to the pharmaceutical industry. Specifically, its classification as a biopharmaceutical company indicates its focus on developing drugs derived from biological sources or through biotechnological processes, which often involves advanced research and development. ### Public Company Status Karuna Therapeutics is an instance of a public company, a classification that defines its operational and financial structure. A public company is characterized by its ability to offer its securities, such as stocks, for sale to the general public, typically through a stock exchange. This structure is a fundamental pillar of modern capitalism, enabling large-scale capital formation essential for business expansion, innovation, and significant projects, particularly in research-intensive fields like biopharmaceuticals. The company's shares are traded on the Nasdaq stock exchange, a prominent global electronic marketplace for buying and selling securities. Its shares are identified by the ticker symbol KRTX. Karuna Therapeutics commenced trading on Nasdaq on June 28, 2019. As a public entity, it is required to adhere to strict regulatory disclosure and reporting standards, which are designed to promote transparency for its investors. The company's Central Index Key (CIK) is 0001771917, a unique identifier used by the U.S. Securities and Exchange Commission (SEC). ### Online Presence and Identifiers Karuna Therapeutics maintains a robust online presence to communicate with stakeholders and the public. Its official website, accessible at https://karunatx.com/, provides information about the company's mission, pipeline, and corporate updates. The website's content is available in English. The company is also active on social media platforms. Its Twitter account, @karunapharma, has been active since September 10, 2018, with its status last noted on March 6, 2023. Additionally, Karuna Therapeutics can be found on LinkedIn under the identifier 'karuna-therapeutics', serving as a professional networking and information platform. Further identifiers for Karuna Therapeutics include its Crunchbase organization ID, listed as 'karuna-pharmaceuticals'. The company's global recognition is also evidenced by its presence on Wikipedia, with an entry available in Japanese (ja).